havas glp-1 Shape Shifting: A Close Look at the Health and Wellness Disruptor — GLP-1” is happening in Paris on March 13th! Check out the full agenda and get ready for expert-led discussions on Havas launches creator-led docuseries 'Shape

The science of slowed gastrointestinal motility GLP-1 receptor agonists act on the gutbrain axis and are known to slow gastric emptying and overall gastrointestinal transit , contributing to early satiety and appetite suppression. As intestinal transit slows, the colon has more time to absorb water from stool , leading to hard, dry stools that are difficult to pass . Constipation is a common, dose-related adverse effect listed in FDA prescribing information for both Wegovy (semaglutide) and Zepbound (tirzepatide) and is most frequently reported during dose escalation , with improvement over time., Step-by-Step MD Protocol for Relief 1

Your skin is worth that kind of attention

Evaluating Patient Health With Micronutrient Testing To determine if your patients have healthy levels of nutrients, consider precision testing like the Micronutrient Panel

Volkskrankheit Adipositas: mit Diabetesmedikament zum Traumgewicht

Utility of neuronal-derived exosomes to examine molecular mechanisms that affect motor function in patients with Parkinson disease: a secondary analysis of the exenatide-PD trial